Ann Dermatol.
2011 Dec;23(Suppl 3):S360-S363. 10.5021/ad.2011.23.S3.S360.
Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec(TM))
- Affiliations
-
- 1Department of Dermatology, College of Medicine, Chungnam National University, Daejeon, Korea. jhoon@cnu.ac.kr
- KMID: 2171872
- DOI: http://doi.org/10.5021/ad.2011.23.S3.S360
Abstract
- Imatinib mesylate (Gleevec(TM), STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Although its use has been associated with various adverse cutaneous reactions, pityriasis rosea-like drug eruptions are rare. Here, we report a case of pityriasis rosea-like drug eruption that developed following the administration of imatinib mesylate to treat CML.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Imatinib Mesylate (Gleevec(TM))-induced Lichenoid Drug Eruption Improved by Tentative Dose-reduction and Topical Steroid
- A Case of Lichenoid Drug Eruption Associated with Imatinib Mesylate
- Comments to "A Case of Pityriasis Rosea Associated with Leuprolide Acetate"
- A Case of Drug Eruption with Periorbital Edema and Exfoliative Dermatitis Induced by Imatinib Mesylate (STI571, Gleevec(TM))
- Imatinib-induced Psoriasiform Drug Eruption in a Patient with a Gastrointestinal Stromal Tumor
